Biotechnology Product Development and Biotherapeutics

Introduces the journey from a biological idea to a product that can be manufactured, tested and delivered to a patient. It establishes how scientific, technical and clinical decisions connect across the product lifecycle.

The pathway is presented as a connected chain rather than a collection of isolated steps. A change in the biological target, production method or formulation can affect quality, cost, performance and the final use of the product.

Connects molecular biology, bioprocessing, formulation and end-user needs into one development pathway. The focus is on moving from a promising biological product to a design that can be developed consistently and responsibly.

This section frames product development as a sequence of decisions and evidence. The product must be scientifically credible, manufacturable at the required scale, suitable for its intended use and supported by controls that protect the user.

Explores cell growth, expression systems, culture conditions and the choices that affect yield, consistency and product quality. Learners see why the production system and its operating conditions determine what can be recovered downstream.

Upstream work creates the biological material that downstream processing must recover. The course considers microbial and mammalian systems, growth media and process conditions, showing how small changes can influence productivity, reproducibility and the characteristics of the product.

Follows the product after production through recovery, separation and purification. It highlights the controls needed to remove impurities, protect the molecule and obtain a product suitable for formulation and further testing.

Downstream processing turns a complex biological mixture into a defined product. Recovery, clarification, concentration and purification must work together while preserving the molecule’s structure and activity and meeting the expected quality requirements.

Examines how risks are identified and controlled across development and manufacturing. Quality is treated as something designed into the process, not something checked only after production is complete.

Quality and risk management connect scientific understanding with practical controls. The aim is to anticipate sources of variation, assess their impact and build monitoring, documentation and corrective action into the way the product is made.

Uses vaccines as a practical example of biotherapeutic development, linking antigen design, production, formulation and performance. The topic shows how scientific choices become measurable product and public-health outcomes.

Vaccines make the wider development pathway concrete: the active biological component must be selected, produced, stabilised and shown to generate the intended immune response. The section also highlights the scale, consistency and safety expectations that shape vaccine manufacture.

Explains how adjuvants shape immune responses and the development and manufacturing decisions behind an effective vaccine. It considers why the adjuvant is part of the product design rather than an afterthought.

An adjuvant can strengthen, direct or prolong the immune response to an antigen. Its selection affects dose, tolerability, stability, manufacturing and the way the finished vaccine performs, so it must be considered alongside the antigen from the beginning.

Introduces formulation as the bridge between a biological molecule and a stable, safe and usable finished product. Learners consider how composition, conditions and delivery requirements influence the final dosage form.

Biological molecules can be sensitive to temperature, pH, interfaces, light and mechanical stress. Formulation brings together the molecule, excipients, container and delivery route so that the product remains safe, effective and practical to use.

Builds on stability, delivery and performance considerations, showing how formulation protects product quality through its lifecycle. The course brings formulation back to the practical goal: preserving a biotherapeutic until it reaches the person who needs it.

The later formulation work considers how stability is tested and how degradation or loss of activity can be reduced. It reinforces that a successful formulation must perform consistently during storage, transport and administration, not only at the moment it is produced.